ScholarWorks@Korea University College of Medicine: Rim, Chai Hong

Detailed Information

Rim, Chai Hong (임채홍)

Ansan Hospital (Department of Radiation Oncology, Ansan Hospital)

Research Area: 간세포암, 폐암, 정위방사선치료, Hepatocellular carcinoma, Lung cancer, Stereotactic body radiotherapy

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Radiotherapy:18||radiotherapy:18||hepatocellular carcinoma:14||Hepatocellular carcinoma:11||Stereotactic body radiotherapy:9||metaanalysis:8||radiation therapy:6||Liver neoplasm:5||Metaanalysis:5||Breast cancer:5||liver neoplasm:4||Oligometastasis:4||Radiation therapy:4||lung cancer:4||external beam radiotherapy:4||Surgery:4||inferior vena cava:3||IntensityModulated Radiation Therapy:3||Utilization:3||Colorectal neoplasms:3||Radiofrequency ablation:3||prevention:3||Cholangiocarcinoma:3||sorafenib:3||stereotactic body radiotherapy:3||surgery:3||survival:3||External beam radiation therapy:3||Korea:2||Zebrafish:2||Head and neck cancer:2||Inferior vena cava:2||Recurrence:2||radioprotectant:2||mistletoe:2||Uzbekistan:2||diet:2||Cambodia:2||Right atrium:2||right atrium:2||external beam radiation therapy:2||Quality of life:2||feasibility:2||treatment:2||BCLC C:2||stereotactic ablative body radiotherapy:2||Survival:2||interpretation:2||guidelines:2||head and neck cancer:2||South Korea:2||ultracentral tumor:2||Portal vein thrombosis:2||liver cancer:2||systematic review:2||intensitymodulated radiotherapy:2||oligometastasis:2||breast cancer:2||Cancer:2||portal vein thrombosis:2||Radiation oncology:2||transarterial chemoembolization:2||central tumor:2||Breast neoplasm:2||Open Access Scholarly Publishers Association:1||Open access:1||Overall survival:1||Physical activity:1||Pituitary adenoma:1||Portal vein:1||Practice guideline:1||Predatory:1||Prognostic factors:1||Radiation exposure:1||Radiation oncologists:1||Radiosensitivity:1||Radiosurgery:1||Reirradiation:1||Rectal cancer:1||Reirradiation:1||Resection:1||Selective internal radiotherapy:1||Setup uncertainty:1||Spinal metastasis:1||Stereotactic Radiotherapy:1||Stereotactic ablative body radiotherapy:1||Stereotactic radiotherapy:1||Survival rate:1||Survivorship:1||Systemic treatment:1||Tumorassociated neutrophils:1||Volunteerism:1||bone metastasis:1||brain metastasis:1||cancer:1||cancer survivor:1||cellfree DNA:1||chemoradiotherapy:1||clinical trials:1||combination:1||combined:1||comparative studies:1||concurrent:1||dietary habit:1||estradiol:1||food:1||gastric cancer:1||hepatocellular:1||highdose:1||human epidermal growth factor receptor 2 (HER2):1||hypertension:1||hypothesis:1||immune checkpoint inhibitor:1||immunotherapy:1||local treatment:1||lymph node:1||lymph node metastasis:1||mastectomy:1||medical volunteering:1||metastasis:1||methodology:1||nonsmall cell lung carcinoma:1||observational studies:1||observational study:1||oligometastasis:1||oligometastases:1||oligometastatic cancer:1||perioperative:1||postmenopause:1||quality of life:1||questionnaire:1||radiation oncology:1||radiochemotherapy:1||radiofrequency ablation:1||radiomics:1||randomized study:1||reconstruction:1||recurrence:1||reirradiation:1||salvage:1||scoring model:1||screening:1||statistics:1||stereotactic body radiation therapy:1||stereotactic body radiotherapy (SBRT):1||stomach cancer:1||supraclavicular lymph node:1||synergy:1||targeted therapy:1||toxicity:1||trastuzumab:1||tumor:1||ultracentral (UC) tumor:1||3D printer:1||validity:1||ALBI grade:1||Ablation:1||Ablative dose:1||Adjuvant:1||Adjuvant radiotherapy:1||Appraisal of Guidelines for Research and Evaluation:1||Asia:1||Beall's list:1||Biomarkers:1||Body mass index:1||Bone metastasis:1||Cancers in the pancreatobiliary region:1||Carcinoma:1||Carcinoma, hepatocellular:1||Clinical guideline:1||Clinical practice guidelines:1||Clinical trials:1||Colorectal surgeon:1||Complication:1||Complications:1||Contemporary treatment:1||Cumulative dose:1||D2 gastrectomy:1||Deep inspiration breath holding:1||Dietary habits:1||Directory of Open Access Journals:1||Dose fractionation:1||Dose perturbation:1||EORTCQLQBR23:1||EQ5D:1||Effective dose:1||Efficacy:1||Embolization, therapeutic:1||Evidencebased medicine:1||External beam radiation:1||Extrahepatic cholangiocarcinoma:1||Gallbladder neoplasm:1||Gender:1||General practice:1||Graded prognostic assessment:1||Heart:1||Hepatic arterial infusion chemotherapy:1||Hypofraction:1||Immunotherapy:1||Intrahepatic malignancy:1||Isoflavones:1||Learning curve:1||Ligation:1||Liver cancer:1||Liver failure:1||Liver metastasis:1||Local therapy:1||Lung cancer:1||Lymphedema:1||Medical research:1||Mesenchymalepithelial transition:1||Metallic biliary stent:1||NSCLC:1||NSCLC IIIC:1||Network metaanalysis:1||Nomogram:1||Nonsmall cell lung cancer:1||Nonsmallcell lung carcinoma:1||

STATISTICS: Total View :12,805,730; Today View :2,518

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE